← Leaderboards
Qin Wang
Augusta University
$13,481,003
Attributed
$16,551,564
Total exposure
11
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.9M · FY2007–25$5M$3.8M$2.5M$1.3M$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$16,551,564 · 11
By mechanism
R01$11,190,928 · 5
RF1$4,054,354 · 2
R21$1,157,782 · 3
R03$148,500 · 1
Top collaborators
- Kai Jiao6 shared
- Lucas D. Pozzo-Miller4 shared
- Hongwei Qin3 shared
- Lizhong Wang1 shared
Most similar at Augusta University
Same institution · by research overlap
- Ferenc Deak$1,919,792
- Nahid F Mivechi$12,726,946
- Paul Jerome Bernard$580,020
- Anil G Cashikar$1,538,302
- Xin-Yun Lu$15,785,318
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposSignal TransductionNeuronsMolecularBrainReceptorMediatingCognitionResponseComplexRegulationBehaviorIn VivoTherapeutic TargetPlayAdrenergic ReceptorAgonistCognitiveCellsPathway InteractionsGtp-Binding ProteinsInsightFutureS Disease
Grant awards (35)
The Role of CHD7 in ACC neurons$681,473
R01 · FY2025 · MH · contact PI
Astrocytic OSMR/JAK/STAT signaling in AD$626,766
R01 · FY2025 · AG · contact PI
The Role of CHD7 in ACC neurons$700,917
R01 · FY2024 · MH · contact PI
Astrocytic OSMR/JAK/STAT signaling in AD$624,157
R01 · FY2024 · AG · contact PI
Regulation of SORLA by beta-arrestin2$529,065
R01 · FY2024 · AG · contact PI
Beta amyloid-adrenergic receptor interaction in Alzheimer's Disease$434,938
R01 · FY2024 · AG · contact PI
The Role of CHD7 in ACC neurons$699,506
R01 · FY2023 · MH · contact PI
Astrocytic OSMR/JAK/STAT signaling in AD$637,657
R01 · FY2023 · AG · contact PI
The Role of CHD7 in ACC neurons$689,855
R01 · FY2022 · MH · contact PI
Beta amyloid-adrenergic receptor interaction in Alzheimer's Disease$434,938
R01 · FY2022 · AG · contact PI
Beta amyloid-adrenergic receptor interaction in Alzheimer's Disease$419,404
R01 · FY2021 · AG · contact PI
Regulation of SORLA by beta-arrestin2$1,531,943
RF1 · FY2020 · AG · contact PI
Regulation of SORLA by beta-arrestin2$486,941
RF1 · FY2020 · AG · contact PI
Beta amyloid-adrenergic receptor interaction in Alzheimer's Disease$431,284
R01 · FY2020 · AG · contact PI
Establish Mouse Models to Evaluate Androgen Deprivation Therapy on AD$408,375
R21 · FY2020 · AG
Test the role of cardiac expressed SEMA6D in Alzheimer's disease$74,250
R03 · FY2020 · AG · contact PI
Beta amyloid-adrenergic receptor interaction in Alzheimer's Disease$411,237
R01 · FY2019 · AG · contact PI
Regulation of novel alpha2A adrenergic receptor signaling by spinophilin$367,500
R01 · FY2019 · MH · contact PI
Regulation of novel alpha2A adrenergic receptor signaling by spinophilin$217,261
R01 · FY2019 · MH · contact PI
Test the role of cardiac expressed SEMA6D in Alzheimer's disease$74,250
R03 · FY2019 · AG · contact PI
Alpha2 adrenergic signaling in AD pathogenesis$1,117,224
RF1 · FY2018 · AG · contact PI
Alpha2 adrenergic signaling in AD pathogenesis$918,246
RF1 · FY2018 · AG · contact PI
Regulation of novel alpha2A adrenergic receptor signaling by spinophilin$367,500
R01 · FY2018 · MH · contact PI
Regulation of novel alpha2A adrenergic receptor signaling by spinophilin$367,500
R01 · FY2017 · MH · contact PI
Regulation of novel alpha2A adrenergic receptor signaling by spinophilin$378,275
R01 · FY2016 · MH · contact PI
Regulation of novel alpha2A adrenergic receptor signaling by spinophilin$378,625
R01 · FY2015 · MH · contact PI
Regulation of alpha2A-adrenergic receptor signaling and trafficking by spinophili$344,520
R01 · FY2013 · MH · contact PI
Preclinical test for the efficacy of adrenergic agents in treatment of AD$173,545
R21 · FY2013 · AG · contact PI
Regulation of alpha2A-adrenergic receptor signaling and trafficking by spinophili$358,875
R01 · FY2012 · MH · contact PI
Preclinical test for the efficacy of adrenergic agents in treatment of AD$219,750
R21 · FY2012 · AG · contact PI
Regulation of alpha2A-adrenergic receptor signaling and trafficking by spinophili$358,875
R01 · FY2011 · MH · contact PI
Regulation of alpha2A-adrenergic receptor signaling and trafficking by spinophili$368,300
R01 · FY2010 · MH · contact PI
Regulation of alpha2A-adrenergic receptor signaling and trafficking by spinophili$362,500
R01 · FY2009 · MH · contact PI
Regulation of alpha2A-AR trafficking/signaling by different agonists in neurons$194,243
R21 · FY2008 · MH · contact PI
Regulation of alpha2A-AR trafficking/signaling by different agonists in neurons$161,869
R21 · FY2007 · MH · contact PI